(Table 1) with the results of the previous investigations [3] shows that, in the case of the hydroxy- and
alkoxyanilides, the transition from pyrroloquinoline derivatives to their 5-methyl-substituted analogs is
accompanied by some decrease in diuretic activity but that the overall nature of the structure–biological
relationship remains the same.
EXPERIMENTAL
1H NMR spectra of anilides 1a-j were measured on a Varian Mercury VX-200 instrument (200 MHz)
with DMSO-d6 solvent and TMS as internal standard. The synthesis of ethyl 6-hydroxy-2-methyl-4-oxo-
2,4-dihydro-1H-pyrrolo[3,2,1-ij]quinoline-5-carboxylate (2) and its amidation by hydroxy- and alkoxyanilines
was carried out by the method in the study [2].
X-ray Structural Investigation. Crystals of the 4-ethoxyanilide 1h are monoclinic (DMF), at 20ºC:
a = 7.5136(7), b = 9.8478(7), c = 23.673(2) Å, = 96.160(7)º, V = 1741.5(2) Å3, Mr = 364.39, Z = 4, space
group P21/n, dcalc = 1.390 g/cm3, (MoK) = 0.097 mm-1, F(000) = 768. Unit cell parameters and intensities for
13731 reflections (3062 independent, Rint = 0.047) were measured on an Xcalibur-3 diffractometer (MoK
radiation, CCD detector, graphite monochromator, -scanning, 2max = 50º).
The structure was interpreted by a direct method using the SHELXTL program package [11]. In the
structure refinement a limit was placed on the ethyl group bond length of 1.54(1) Å. The positions of the
hydrogen atoms were revealed from electron density difference synthesis and refined using the "rider" model
with Uiso = nUeq for a non-hydrogen atom bonded to the given hydrogen (n = 1.5 for a methyl group and n = 1.2
for other hydrogen atoms). Hydrogen atoms involved in formation of hydrogen bonds were refined in the
isotropic approximation. The structure was interpreted by F2 full-matrix least-squares analysis in the anisotropic
approximation for non-hydrogen atoms to wR2 = 0.073 for 3023 reflections (R1 = 0.035 for 1585 reflections with
F > 4 (F), S = 0.760). The full crystallographic information for the 4-ethoxyanilide 1h has been placed in the
Cambridge Crystallographic Data Center as deposit CCDC 801477. Interatomic distances and valence angles are
given in Tables 3 and 4, respectively.
REFERENCES
1.
2.
I. V. Ukrainets, E. V. Mospanova, O. V. Gorokhova, and S. V. Shishkina, Khim. Geterotsikl. Soedin.,
1232 (2011). [Chem. Heterocycl. Comp., 47, 1014 (2011)].
I. V. Ukrainets, N. Yu. Golik, A. L. Shemchuk, O. I. Naboka, Yu. V. Voronina, and A. V. Turov, Khim.
Geterotsikl. Soedin., 1009 (2011). [Chem. Heterocycl. Comp., 47, 826 (2011)].
E. V. Mospanova, Diss. Cand. Pharmaceut. Sci., Kharkiv (2008).
3.
4.
5.
6.
Yu. V. Skripinets, Diss. Cand. Chem. Sci., Odessa (2007).
V. A. Parshikov, Diss. Cand. Pharmaceut. Sci., Kharkiv (2009).
I. V. Ukrainets, E. V. Mospanova, A. A. Davidenko, A. A. Tkach, and O. V. Gorokhova, Khim.
Geterotsikl. Soedin., 1173 (2010). [Chem. Heterocycl. Comp., 46, 947 (2010)].
H.-B. Burgi and J. D. Dunitz, Structure Correlation, Vol. 2, VCH, Weinheim (1994), p. 741.
Yu. V. Zefirov, Kristallografiya, 42, 936 (1997).
L. N. Sernov and V. V. Gatsura, Elements of Experimental Pharmacology [in Russian], Moscow (2000),
p. 103.
7.
8.
9.
10.
11.
M. D. Mashkovskii, Drugs [in Russian], Novaya Volna, Umerenkov, Moscow (2009), p. 499.
G. M. Sheldrick, Acta Crystallogr., A64, 112 (2008).
1127